Dr. Andrew Mahon joined the Division of Hematology in 2015 as a Research Assistant Professor. He is committed to drug development efforts that involve collaborations with the Departments of Hematology and also Biochemistry. He has a special interest in bioorganic chemistry, protein-protein interactions, and small molecule synthesis.
Dr. Mahon completed a Bachelor of Science in 2000 and a Ph.D. in Organic Chemistry in 2008 in the laboratory of Dr. Andrew C. Try at Macquarie University, Sydney, Australia. In 2009 he moved to the California Institute of Technology (Caltech) for postdoctoral studies, where he explored small molecule synthesis and conformational analysis with nuclear magnetic resonance techniques in the laboratory of Prof. John D. Roberts. At Caltech, he also spent a significant portion of his time mentoring junior researchers. In 2010 he continued his postdoctoral studies at New York University where he developed a method for the synthesis of short stable peptide helices to probe protein-protein interactions. In 2012 Dr. Mahon became a senior scientist at PHD Biosciences where he focuses on small molecule drug development in the areas of oncology and sickle cell disease.